|
SORL1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.70907732410797E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.70163882984298E-12 |
| Normal-vs-Stage2 |
7.89420000479879E-08 |
| Normal-vs-Stage3 |
9.8819952221163E-11 |
| Normal-vs-Stage4 |
2.32569999999432E-05 |
| Stage1-vs-Stage2 |
9.968200E-01 |
| Stage1-vs-Stage3 |
3.474200E-01 |
| Stage1-vs-Stage4 |
8.082600E-01 |
| Stage2-vs-Stage3 |
4.964800E-01 |
| Stage2-vs-Stage4 |
8.143000E-01 |
| Stage3-vs-Stage4 |
8.094600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62536650805123E-12 |
| Normal-vs-AfricanAmerican |
1.50421999999262E-05 |
| Normal-vs-Asian |
4.219000E-04 |
| Caucasian-vs-AfricanAmerican |
6.956500E-02 |
| Caucasian-vs-Asian |
9.547800E-01 |
| AfricanAmerican-vs-Asian |
1.910970E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.6885381981524E-12 |
| Normal-vs-Female |
3.9834999743249E-09 |
| Male-vs-Female |
3.562400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.71399999970845E-07 |
| Normal-vs-Extreme_Weight |
6.23034956959145E-12 |
| Normal-vs-Obese |
2.92950108615742E-11 |
| Normal-vs-Extreme_Obese |
1.86732999999384E-05 |
| Normal_Weight-vs-Extreme_Weight |
4.604800E-01 |
| Normal_Weight-vs-Obese |
6.719800E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.442800E-01 |
| Extreme_Weight-vs-Obese |
1.146360E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.495400E-01 |
| Obese-vs-Extreme_Obese |
4.155400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.010400E-04 |
| Normal-vs-Age(41-60Yrs) |
8.43769498715119E-15 |
| Normal-vs-Age(61-80Yrs) |
1.73099978795221E-10 |
| Normal-vs-Age(81-100Yrs) |
7.25529969436423E-10 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.517400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.110800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.351980E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.756800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.963370E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.797800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.93169949322692E-11 |
| Normal-VS-Type2 PRCC |
4.2854608750531E-14 |
| Normal-VS-KIRP CIMP |
2.161700E-02 |
| Normal-VS-Unclassified PRCC |
5.53099999999196E-05 |
| Type1 PRCC-VS-Type2 PRCC |
4.897800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.173800E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.798240E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.262130E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
5.562000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.908400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.09460013170337E-10 |
| Normal-vs-N1 |
2.99870000053382E-07 |
| Normal-vs-N2 |
3.939900E-03 |
| N0-vs-N1 |
3.804200E-01 |
| N0-vs-N2 |
9.318400E-01 |
| N1-vs-N2 |
6.285800E-01 |
|
|
